Adaptimmune Therapeutics PLC
ADAPY- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001621227
No open-market purchases or sales by Adaptimmune Therapeutics PLC insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Adaptimmune Therapeutics PLC changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 65 | 89 | +24 |
| Shares | 116.0M | 144.7M | +28.8M (+24.8%) |
| Value | $126.4M | $133.9M | +$7.47M (+5.9%) |
New holders (34)
Institutions that held Adaptimmune Therapeutics PLC at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (10)
Institutions that held Adaptimmune Therapeutics PLC at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Virtu Financial LLC | 88,234 | $96.0K |
| SEI Investments Co | 47,409 | $51.7K |
| Vigilare Wealth Management | 28,800 | $31.4K |
| HRT Financial LP | 18,047 | $19.0K |
| Commonwealth of Pennsylvania Public School Empls Retrmt Sys | 14,287 | $15.6K |
| State of Tennessee, Treasury Department | 13,100 | $14.3K |
| ProShare Advisors LLC | 10,077 | $11.0K |
| GWM Advisors LLC | 900 | $981 |
| Clearstead Advisors, LLC | 500 | $545 |
| Advisory Services Network, LLC | 325 | $354 |